ÂÜÀòÂÒÂ×

Sree Kant is the Founder and CEO of BAKX Therapeutics. Prior to BAKX, Sree was Head of Business Development at Life Biosciences where they oversaw investments, strategic partnerships, R&D portfolio strategy, company creation, M&A and R&D models. Sree has also built strategic investment theses for Life Bio investments and led the Scientific and Strategic evaluation of investment opportunities in areas such as Autophagy, Senescence, Metabolic dysfunction, DNA repair, Genetic reprogramming, Iron Channel modulation, AI, and Animal health. Sree has also represented Life bio at various avenues as speaker and panelist on subjects of new business models and novel investment paradigms in ageing, longevity research, partnering structures, etc.

After completing a Bachelor's in Engineering at Bangalore University's BMS College of Engineering, Sree Kant pursued a Masters in Business Administration at the Indian Institute of Management Bangalore. Sree then completed an MPH in International Health at Harvard University.

Gwyneth Hannagan - Executive Assistant & Administrative Manager, Dazhi Tan - Lead, Computational Drug Discovery, and Wendy Rieder - Acting General Counsel report to Sree Kant.